MedPath

Non Steroidal Antiinflammatory Drugs Influence on Heal of Distal Radius Fracture

Phase 3
Completed
Conditions
Forearm Fracture
Interventions
Drug: Placebo
Registration Number
NCT01567072
Lead Sponsor
Marius Aliuskevicius
Brief Summary

It is believed, that Non Steroidal Antiinflammatory Drug (NSAID) drugs slows bone healing, but the knowledge is based only on animal studies, and the results are automatically raised for the people.

Many patients with bone fracture must therefore avoid the formerly so popular and good painkillers, although no clinical trial evidence is, that this medicine is really harmful for patients with fractures.

The purpose of this study is to investigate whether these drugs slows bone healing, and what the relationship is between various bone studies - DEXA scanning, biochemical bone marker tests, radiographic controls and tissue examination of newly formed bone under a microscope. How sensitive and specific, each of the above study methods? If they are just as sensitive, the cheapest of them recommended as a routine investigation on suspicion of bone effects. Furthermore, to compare the benefit (pain-relieving effect, influence on rehabilitation) of these drugs and their possible harmful side effects (affected and delayed bone healing).

The expectation is that the study may contribute to increased knowledge about NSAIDs effect do pain management, rehabilitation and the entire treatment process significantly easier and safer, so that patients recover faster and return to usual activities.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
192
Inclusion Criteria
  • written acceptance to participate in the study
  • immobilisation or reposition or surgery demanding Colles fracture (which needs to be fixed with external fixation).
Exclusion Criteria
  • age - younger than 50 years or older than 80 years
  • treatment with prednisolon
  • NSAIDs - treatment
  • previous fracture or surgery at the wrist
  • lack of mental and physical capacity to follow studies' instructions
  • lack of informed consent
  • other diseases can affect bone substance (oncology, endocrine diseases)
  • medical contraindications to NSAIDs use
  • smoking, alcohol consumption of more than 14 drinks per week
  • secondary dislocation of fracture also apply as exclusion criterion.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NSAIDs in 3 daysIbuprofenNSAIDs (Ibuprofen) in the first 3 days and placebo in the last 4 days
PlaceboPlaceboOnly placebo in 7 days
NSAIDs in 7 daysIbuprofenNSAIDs (Ibuprofen) in 7 days
Primary Outcome Measures
NameTimeMethod
Evaluation of changes of fractures position by X rays investigation1 week, 2 weeks, 6 weeks

Measurement of possible secondary dislocation

Secondary Outcome Measures
NameTimeMethod
Bone Biochemical markers1 week, 2 weeks, 5 weeks, 3 months, 1 year

Se CrossLaps ELISA, N/Mid Osteocalcin Elisa

Histomorfometrical evaluation of bone biopsy from callus area6 weeks

qualitative evaluation of bone ossification

DEXA - scanning12 weeks

Evaluation of bone density

Trial Locations

Locations (1)

Department of Orthopaedic Surgery, Aalborg University Hospital

🇩🇰

Aalborg, Denmark

© Copyright 2025. All Rights Reserved by MedPath